News

Summer 2017
NOW RECRUITING! See Job Offers & Student Scholarships
August 2017
NEW TEAM MEMBER! Welcome to Guillaume Béraud (Postdoctoral Fellow)
May 2017
Marc Brisson was at the World Health Organization's workshop 'WHO Blueprint Plan of Action - Designing a vaccine efficacy trial during Public Health Emergencies: Towards the development of guidelines and interactive tools'. The workshop was held 1-2 May 2017 in Annecy, France.
May 2017
Marc Brisson has ranked 1st in the 2017-2018 Research Scholars Junior 2 competition of the 'Fonds de recherche du Québec - Santé' (FRQS).
May 2017
Marc Brisson is a principal investigator on a $ 10 million grant for the Canadian Immunization Research Network (CIRN) obtained from the Public Health Agency of Canada (PHAC) and the Canadian Institutes of Health Research (CIHR).
January 2017
PUBLICATION IN THE AMERICAN JOURNAL OF EPIDEMIOLOGY: 'Bias Due to Correlation Between Times-at-Risk for Infection in Epidemiologic Studies Measuring Biological Interactions Between Sexually Transmitted Infections: A Case Study Using Human Papillomavirus Type Interactions.' [ PubMed ]
January 2017
WHO IVIR-AC MEETING. Marc Brisson participated to the meeting of the Immunization and Vaccines Related Implementation Research (IVIR) Advisory Committee (IVIR-AC) on ‘Ad-Hoc Expert Consultation on Clinical Trials of Non-Specific Effects of Vaccines’ at Veyrier-du-Lac, France, January 30-31, 2017
January 2017
NEW TEAM MEMBER! Welcome to Karine Larouche (Master Student in Epidemiology)
December 2016
Our team's research work is cited in ACIP's recommendations for 'Use of a 2-Dose Schedule Human Papillomavirus Vaccination' [ CDC ]
December 2016
SAGE-WHO MEETING. SAGE issued recommendations regarding introduction of HPV vaccination in low to middle income countries based partly on modeling results presented by Marc Brisson to SAGE in October 2016. [ WHO ]
November 2016
INTERVIEW IN 'PLANÈTE F' MAGAZINE. Marc Brisson is interviewed about vaccinating boys against HPV [ Planète F ]
November 2016
PUBLICATION IN LANCET PUBLIC HEALTH: 'Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis' [ Lancet Pub Health ] [ Accompanying Comment ]
October 2016
SAGE-WHO MEETING. Marc Brisson presented at the meeting of the WHO Strategic Advisory Group of Experts (SAGE) on immunization held October 18-20, 2016 in Geneva. Results presented at the meeting will be used for WHO recommendations on HPV vaccination at the Global level. [ Meeting Agenda ] [ Summary Report ]
October 2016
ACIP MEETING. ACIP voted to recommend a 2-dose HPV vaccination schedule in the US for girls and boys, based partly on modeling results presented by Marc Brisson to ACIP last June. [ CDC ]
October 2016
PUBLICATION IN EMERGING INFECTIOUS DISEASES: 'Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes' [ Free PMC Article ]
October 2016
PUBLICATION IN CMAJ: 'Effect of HPV on cervical cancer screening in Alberta.' [ PubMed ]
September 2016
PUBLICATION IN PLOS ONE: 'Mathematical Modeling of the Transmission Dynamics of Clostridium difficile Infection and Colonization in Healthcare Settings: A Systematic Review.' [ Free PMC Article ]
June 2016
ACIP MEETING. Marc Brisson was presenting at the meeting of the Advisory Committee on Immunization Practices (Atlanta, June 22-23) [ Summary Report ] [ Meeting Agenda (PDF) ]
June 2016
EUROGIN 2016. Marc Brisson was chair of the session 'The role of modeling and economics' and was invited speaker at EUROGIN 2016: 'What can models tell us about reduced dose schedules?' (Salzburg, June 15-18) [ EUROGIN 2016 ] [ Program (PDF) ]
June 2016
WHO IVIR-AC MEETING. Marc Brisson attended the Immunization and Vaccines Related Implementation Research (IVIR) Advisory Committee (IVIR-AC) of the World Health Organization (WHO) (Geneva, May 30-June 1)
May 2016
PUBLICATION IN THE JOURNAL OF INFECTIOUS DISEASES: 'Comparison of 2-Dose and 3-Dose 9-Valent Human Papillomavirus Vaccine Schedules in the United States: A Cost-effectiveness Analysis.' [ J Infectd Dis ]
May 2016
CONGRATULATIONS TO TALIA! Talía Malagón successfully defended her PhD thesis and obtained the grade of Philosophiae Doctor on May 24th, 2016.
May 2016
CONGRATS LÉA! Léa Drolet-Roy was awarded a bronze medal and a $ 1,000 university scholarship for her project VSV-EBOV contre Ebola at the Canada-Wide Science Fair (CWSF) held last May at McGill University, Montreal. Léa is a high school student coached by our team. [ Collège Saint-Charles Garnier ]
April 2016
Marc Brisson has been appointed full professor at Laval University.
April 2016
CONGRATS LÉA! Léa Drolet-Roy, a high school student coached by our team, was awarded a prize at the ‘Super Expo-sciences Hydro-Québec, Finale Québécoise’ 2016 for her transmission-dynamic modeling project ‘VSV-EBOV contre Ébola’. Léa will be part of the Quebec delegation at the Canada-Wide Science Fair, Montreal May 15-20, 2016. [ CWSF ]
March 2016
PUBLICATION IN VACCINE: 'Can high overall human papillomavirus vaccination coverage hide sociodemographic inequalities? An ecological analysis in Canada' [ PubMed ]
March 2016
PUBLICATION IN THE INTERNATIONAL JOURNAL OF CANCER: 'Eurogin Roadmap 2015: How has HPV knowledge changed our practice: vaccines' [ Int J Cancer ]
February 2016
PUBLICATION IN THE JOURNAL OF INFECTIOUS DISEASES: 'The Impact and Cost-Effectiveness of 3 doses of 9-Valent Human Papillomavirus (HPV) Vaccine among US Females Previously Vaccinated with 4-Valent HPV Vaccine' [ J Infect Dis ]
February 2016
TEACHING AT IMPERIAL COLLEGE. Marc Brisson is giving a Lecture entitled 'Economic Evaluation: from uncertainty quantification to public health decision making' (London, February 11, 2016)
February 2016
WHO MEETING. Marc Brisson is participating in the WHO Ad-hoc Consultation on Epidemiological Studies for Non-Specific Effects of Vaccines (Geneva, 16-17 February 2016)
February 2016
RAC 2016 AWARDS. Our proposal ranked “Outstanding” in Compute Canada's Resource Allocation Competition (RAC) 2016 and we received a 408 core-year allocation on Colosse supercomputer at Laval University, Quebec. [ Compute Canada ]
January 2016
PUBLICATION IN EMERGING INFECTIOUS DISEASES: 'Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior' [ CDC ]
January 2016
NEW TEAM MEMBER! Welcome to Dave Martin (Research professional)
December 2015
Marc Brisson has joined the AIDS and Infectious Disease Network as a nominated researcher [ FRQS ]
November 2015
PUBLICATION IN EPIDEMIOLOGY AND INFECTION: Assortative mixing as a source of bias in epidemiological studies of sexually transmitted infections: the case of smoking and human papillomavirus [ Epidemiol Infect ]
October 2015
PUBLICATION IN JNCI: 'Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States' [ JNCI ]
August 2015
CIHR FUNDING! Marc Brisson awarded a Foundation Scheme grant as Nominated PI ($ 2,384,146 over 7 years): 'Using mathematical modeling and health economics to evaluate and optimize infectious disease prevention strategies' [ CIHR ]
August 2015
PUBLICATION in Lancet Oncology: 'Fewer than three doses of HPV vaccine' [ The Lancet Oncology ]
June 2015
WHO IVIR-AC MEETING. Marc Brisson attended the Immunization and Vaccines Related Implementation Research (IVIR) Advisory Committee (IVIR-AC) (Geneva, June 8-12)
May 2015
CONGRATS ÉLODIE! Élodie Bénard was awarded the 1st prize for the best presentations at the ''Journée de la recherche des étudiants 2015 - Santé des populations et pratiques optimales en santé (SP-POS)''
April 2015
NEW TEAM MEMBERS! Welcome to Guillaume Gingras (Post-doctoral fellow in infectious disease modelling, PhD in Physics) and to Myriam Rousseau (Master student in Epidemiology, BSc in Actuarial Science)
March 2015
PUBLICATION IN THE LANCET ID: Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis [ The Lancet ID ] The publication was accompatnied by a comment [ Comment ]
January 2015
INTERVIEWS IN SCIENTIFIC AMERICAN and 'LE FIL' MAGAZINE about our BMJ paper (Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model BMJ 2015;350:g7584) [ Scientific American ] [ Le Fil ]
January 2015
Philippe Lemieux-Mellouki received a Michael Smith Foreign Study Supplement from CIHR ($ 6,000), to spend 4 months at London School of Hygiene and Tropical Medicine.
January 2015
PUBLICATION IN BMJ: Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission mode [ BMJ ]
December 2014
PAPER ACCEPTED IN LANCET INFECTIOUS DISEASES! More details will follow shortly
November 2014
PAPER ACCEPTED IN BMJ! More details will follow shortly
November 2014
PUBLICATION in Cancer Epidemiol Biomarkers Prev: 'Changing inequalities in cervical cancer: modeling the impact of vaccine uptake, vaccine herd effects, and cervical cancer screening in the post-vaccination era' [ PubMed ]
October 2014
NEW TEAM MEMBER! Welcome to Marie-Hélène Guertin (Research professional)
October 2014
ACIP MEETING. Marc Brisson is presenting at the meeting of the Advisory Committee on Immunization Practices (Atlanta, October 29-30) [ Summary Report ] [ Meeting Agenda ]
September 2014
WHO IVIR-AC MEETING. Marc Brisson attended the Immunization and Vaccines Related Implementation Research (IVIR) Advisory Committee (IVIR-AC) (Geneva, September 17-19)
August 2014
IVIR-WHO. Marc Brisson has been selected to be part of the Advisory Committee on Immunization and Vaccines-related Implementation Research (IVIR) of the World Health Organization (WHO)
August 2014
INTERVIEWED BY 'LE FIL' MAGAZINE. Marc Brisson was interviewed by Le Fil magazine about a tool he helped develop to assist decision-making on HPV vaccination in low income countries [ Le Fil ]
August 2014
PUBLICATION IN VACCINE: Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study [ Vaccine ]
August 2014
CONFERENCE. Philippe Lemieux-Mellouki had an oral poster presentation at the 29th International Papillomavirus Conference, Seattle, USA [ HPV 2014 Seattle ]
August 2014
CIHR FUNDING: Canadian Immunization Research Network (CIRN). Marc Brisson is PI and lead of the Modelling infrastructure and the Modelling and health Economic Research Network (ModERN) ($ 6.6 million over 3 years) [ CIHR ]
August 2014
CIHR FUNDING. Marc Brisson is awarded (as nominated PI) a $ 533,000 operating grant over 5 years entitled 'Reducing the burden of hospital-associated Clostridium difficile infections in Canada through optimal prevention policies: A multidisciplinary individual-based modeling approach' [ CIHR ]
June 2014
PUBLICATIONS in Lancet Global Health: 'Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study' [ WHO, LSHTM ]
May 2014
INPUT ON POLICY. Our modeling work has been used to inform policy decisions to switch from a 3-dose to a 2-dose HPV immunisation schedule in Québec, and in UK
May 2014
NEW TEAM MEMBER! Welcome to Andréanne Savard (Master student)
May 2014
CONGRATS Philippe Lemieux-Mellouki, 2nd prize for the best oral presentation at the 'Journée de la recherche des étudiants de l'axe SP-POS' at the CR-CHU de Québec. [ Centre de recherche du CHU de Québec ]
April 2014
SAGE-WHO MEETINGS. Marc Brisson presented at the meeting of the WHO Strategic Advisory Group of Experts (SAGE) on immunization held April 4, 2014 in Geneva [ Presentation ] [ SAGE meeting ]
April 2014
PUBLICATION IN VACCINE: Two-dose strategies for human papillomavirus vaccination: How well do they need to protect? [ Vaccine ]
March 2013
NEW TEAM MEMBER! Welcome to Aminata Mboup (Research assitant)
February 2014
TEACHING AT IMPERIAL COLLEGE. Marc Brisson gave a Lecture entitled 'Economic Evaluation: from uncertainty quantification to public health decision making'
January 2014
RADIO INTERVIEW. Talía Malagón interviewed for the CBC radio program Les Années-lumières: Une mathématique de la vaccination avec Talía Malagón [ ici.radio-canada.ca ]
November 2013
CONGRATS Talía Malagón for receiving the Didier-Mouginot PhD fellowship from the CHU de Québec foundation [ CR-CHU de Québec ]
September 2013
CIHR FUNDING! Marc Brisson awarded a 4 year Operating Grant entitled 'Universal childhood varicella vaccination program: will it protect or harm the immigrant population?' [ CIHR ]
August 2013
PUBLICATION in Vaccine: 'Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: A transmission-dynamic modeling study' [ Vaccine ]
August 2013
CONGRATS Talía Malagón for receiving la Bourse de perfectionnement de l'ACCEM 2013 for a 5 month academic visit at Imperial College, London, UK. [ Faculté de Médecine de l'Université Laval ]
July 2013
PUBLICATION in PLOS One: 'Vaccinating Girls and Boys with Different Human Papillomavirus Vaccines: Can It Optimise Population-Level Effectiveness?' [ PLOS One ]
June 2013
CONGRATS Talía Malagón, Laureate of Fonds Santé Étudiants-chercheurs étoiles for her publication 'Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis' published in The Lancet Infectious Diseases in October 2012. [ Fonds de recherche du Québec ]
May 2013
NEW TEAM MEMBER! Welcome to Élodie Bénard (Master student)
June 2013
WHO MEETINGS. Marc Brisson is attending the meetings of the Immunization and Vaccines Related Implementation Research (IVIR) Advisory Committee (IVIR-AC) and the WHO Strategic Advisory Group of Experts (SAGE) working group on varicella and herpes zoster vaccines in Geneva [ WHO ]
March 2013
EPIDOODLE PRIZE. Talía Malagón has won the EpiDoodle contest held by the Epidemiology Monitor to honour the 200th birthday of epidemiologist John Snow. [ Contest Winner announcement ]
February 2013
TEACHING AT IMPERIAL COLLEGE. Marc Brisson gave a Lecture entitled 'Economic Evaluation: from uncertainty quantification to public health decision making'
Februrary 2013
PUBLICATION in VACCINE 'The impact of differential uptake of HPV vaccine by sexual risks on health inequalities: A model-based analysis' [ PubMed ]
January 2013
PUBLICATION in BMC MEDICINE 'Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts' [ PubMed ]
January 2013
PUBLICATION in HUMAN VACCINES & IMMUNOTHERAPEUTICS 'Vaccination against herpes zoster in developed countries: State of the evidence' [ PubMed ]
January 2013
EDITORIAL in THE JOURNAL OF THE NATIONAL CANCER INSTITUTE. 'Inequalities in Human Papillomavirus (HPV)–Associated Cancers: Implications for the Success of HPV Vaccination' [ JNCI ]
October 2012
HPV-ADVISE published in THE JOURNAL OF THE NATIONAL CANCER INSTITUTE. 'Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis' published with an Editorial [ JNCI ]
October 2012
STUDENT TRAVEL AWARD FOR IPV. Talía Malagón received a travel award for the 28th International Papillomavirus Conference in Puerto Rico.
September 2012
INTERVIEWED BY CONTACT MAGAZINE. Marc Brisson was interviewed by Contact magazine about HPV, varicella and zoster vaccination [ Contact Le Magazine des diplômés et des partenaires de l'Université Laval ]
September 2012
MODELING GOOD PRACTICE REPORTS NOW ONLINE. Marc Brisson is co-author of 'Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5' [ ISPOR Report ]
September 2012
HONORARY SENIOR RESEARCH FELLOW IMPERIAL COLLEGE. Marc Brisson has been named Honorary Senior Research Fellow in the Department of Infectious Disease Epidemiology within the School of Public Health, Faculty of Medicine at Imperial College, London
September 2012
WHO MEETING. Marc Brisson is attending the meeting of the Immunization and Vaccines Related Implementation Research (IVIR) Advisory Committee (IVIR-AC) in Geneva
July 2012
EUROGIN 2012. Marc Brisson is invited speaker at Eurogin 2012, Prague: 'Cost-effectiveness issues: Are they questionable?' [ Eurogin 2012 - Abstracts ]
July 2012
EUROGIN 2012. Talìa Malagòn presented at Eurogin 2012, Prague: 'Cross-protection: How do we interpret trial data, and how important is it at a population-level?' [ Eurogin 2012 - Abstracts ]
July 2012
EUROGIN 2012. Marc Brisson was chair and organizer of the modeling session at Eurogin 2012, Prague. [ Eurogin 2012 ]
June 2012
TEACHING AT OXFORD UNIVERSITY. Marc Brisson is speaking at the 10th anniversary course on infection and immunity in children at Oxford.
June 2012
WHO WORKING GROUP. Marc Brisson has joined the WHO Strategic Advisory Group of Experts (SAGE) working group on varicella and herpes zoster vaccines
June 2012
CONGRATS PHILIPPE! Philippe Lemieux-Mellouki was awarded the gold Governor General's Academic Medal for his master degree in mathematics
May 2012
NEW TEAM MEMBERS! Welcome to Mohamed Amine Amiche (research assistant) and Philippe Lemieux-Mellouki (PhD student)
April 2012
CONGRATS JEAN-FRANCOIS! Jean-François Laprise was awarded a prize for 1 of the 4 best presentations at the ''Conférence des étudiants de l'URESP''
March 2012
MEDIA: Profile of Marc Brisson's research in Le Soleil [ Le Soleil ]
March 2012
MEDIA: Video profile of Marc Brisson for the Faculty of Medicine, Laval University [ YouTube ]
March 2012
CANADA RESEARCH CHAIR RENEWED. Canada Research Chair in Mathematical Modeling and Health Economics of Infectious Disease renewed until the end of 2015! [ Canada Research Chairs ]
March 2012
PUBLICATION in Vaccine 'Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: A 6-month prospective study' [ PubMed ]
February 2012
CIHR FUNDING! Marc Brisson awarded a 3-year Operating Grant entitled 'Reducing inequalities in the burden of human papillomavirus (HPV) related diseases in Canada through optimal vaccination and screening policies: A multidisciplinary model-based approach' [ CIHR ]
February 2012
TEACHING AT IMPERIAL COLLEGE. Marc Brisson gave a Lecture entitled 'Economic Evaluation: from uncertainty quantification to public health decision making'
February 2012
PRESENTATION AT THE CDC. Marc Brisson was invited to present HPV modeling results at the Centers for Disease Control and Prevention, Atlanta, US.
January 2012
MEDIA. Marc Brisson interviewed by Desautels on Radio Canada: 'Le vaccin contre le Virus du Papillome Humain devrait-il être inoculé aux garçons et aux jeunes hommes?' [ CBC radio ]
October 2011
PUBLICATION in Sex Transm Dis 'The impact of anogenital warts on health-related quality of life: a 6-month prospective study' [ PubMed ]
September 2011
CONFERENCE. Our team has 8 Presentations/Posters at the 27th International Papillomavirus Conference, Berlin, Germany [ IPV Berlin ]
August 2011
PUBLICATION in J Infect Dis 'Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity' [ PubMed ]
July 2011
PUBLICATION in Med Decis Making 'Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: a practical guide' [ PubMed ]
June 2011
PUBLICATION in Psychooncology 'The psychosocial impact of an abnormal cervical smear result' [ PubMed ]
May 2011
CONFERENCE. Nicolas van de Velde and Marc Brisson invited to present at the EUROGIN 2011 Congress, Lisbon, Portugal
May 2011
PUBLICATION in Eur J Pain 'Association between prodromal pain and the severity of acute herpes zoster and utilization of health care resources' [ PubMed ]
May 2011
PUBLICATION in Pharmacoeconomics 'Modelling the epidemiology of infectious diseases for decision analysis: a primer' [ PubMed ]
April 2011
PUBLICATION in Sex Transm Infect 'Loss of quality of life associated with genital warts: baseline analyses from a prospective study' [ PubMed ]
February 2011
PUBLICATION in Sex Transm Infect 'Different population-level vaccination effectiveness for HPV types 16, 18, 6 and 11' [ PubMed ]
Login

Admin panel